Decoy Therapeutics (DCOY) Notes Payables (2019 - 2025)
Decoy Therapeutics (DCOY) posted quarterly Notes Payables of $112230.0 for Q1 2025, up 12.23% year-over-year from $100000.0 in Q1 2024, and down 43.89% quarter-over-quarter from $200000.0 in Q4 2024.
Decoy Therapeutics (DCOY) Notes Payables (2019 - 2025) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Notes Payables for 7 consecutive years, with $112230.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Notes Payables rose 12.23% year-over-year to $112230.0; the TTM figure through Mar 2025 stood at $112230.0 (up 12.23% YoY), while the FY2024 annual figure was $200000.0, down 33.33% from the prior year.
- Notes Payables eased to $112230.0 in Q1 2025 per DCOY's latest filing, from $200000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $500000.0 in Q3 2023 and bottomed at $8710.0 in Q1 2022.
- Historically, Notes Payables has averaged $195078.0 across 5 years, with a median of $191395.0 in 2021.
- Annual changes were most pronounced in 2021 — Notes Payables surged 451.7% — and 2022, when it sank 95.45%.
- Decoy Therapeutics' Notes Payables stood at $14518.0 in 2021, then sank by 40.01% to $8710.0 in 2022, then soared by 3344.32% to $300000.0 in 2023, then plunged by 33.33% to $200000.0 in 2024, then plunged by 43.89% to $112230.0 in 2025.
- Business Quant data shows DCOY's Notes Payables at $112230.0 in Q1 2025, $200000.0 in Q4 2024, and $328849.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 112,230.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 328,849.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Mar 31, 2022 | 8,710.00 |
| Dec 31, 2021 | 14,518.00 |
| Mar 31, 2021 | 191,395.00 |
| Dec 31, 2020 | 59,211.00 |
| Sep 30, 2020 | 761,096.00 |
| Mar 31, 2020 | 34,692.00 |
| Dec 31, 2019 | 502,332.00 |
| Sep 30, 2019 | 749,157.00 |